Vol 11 (July 30, 2026): Annals of Thyroid

Editorial Commentary 
Patient-reported tolerability: insights from a secondary analysis of the LIBRETTO-531 study
Amirbahador Golchin, Kara Meister
Annals of Thyroid  
2026;
11:
13
.
Editorial Commentary 
The current landscape of artificial intelligence in the diagnosis of thyroid nodules: a surgeon’s perspective
Aradhya Nigam, Ashok R. Shaha
Annals of Thyroid  
2026;
11:
11
.
Editorial Commentary 
Combination multikinase inhibition and checkpoint blockade in RAIR DTC
Lova Sun, Kartik Sehgal
Annals of Thyroid  
2026;
11:
10
.
Brief Report 
Changes in thyroid-stimulating hormone and thyroxine during hepatitis C virus infection and after direct-acting antiviral therapy independent of interferon exposure: a prospective paired cohort study
Matthew G. Menkart, Jenna L. Oringher, Anjali Rai, Moumita Chakraborty, Gabriella M. Quinn, James A. Haddad, Kareen L. Akiva, Elizabeth C. Townsend, Rabab O. Ali, Christopher Koh, Regina Umarova, Elliot B. Levy, David E. Kleiner, Ohad Etzion, Rownock Afruza, Theo Heller
Annals of Thyroid  
2026;
11:
9
.
Original Article 
Epidemiological data on 25 cases of mixed-etiology thyroid granulomas: a single-center retrospective cross-sectional study
Emma Tam, Kathryn Nunes, K. Rebecca Koob, Stacey M. Gargano, Elizabeth E. Cottrill
Annals of Thyroid  
2026;
11:
8
.